Michail Ignatiadis

Belgium

Research Interests

Explore related searches

Professors in Belgium Professors in Immunology Immunology professors in Belgium

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (14)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2020

Collaborators (10)

Laurence Buisseret

Université libre de Bruxelles (ULB)

BELGIUM

View details

Catherine Alix-Panabières

Associate Professor, Director

University Hospital of Montpellier

FRANCE

View details

Georgios C. Manikis

Karolinska Institutet

SWEDEN

View details

Ioannis Zerdes

Karolinska University Hospital

SWEDEN

View details

Balazs Acs

Karolinska Institutet

SWEDEN

View details

Elisa Agostinetto

Institut Jules Bordet

BELGIUM

View details

Stefanie Jeffrey

John and Marva Warnock Professor

Stanford University

UNITED STATES

View details

Ceren Boyaci

Karolinska University Hospital

SWEDEN

View details

seamus o'reilly

prof

Cork University Hospital

IRELAND

View details

Massimo Cristofanilli

Northwestern University Feinberg School of Medicine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Michail Ignatiadis

Research Interests

Explore related searches

Contact this professor

Articles (14)

Further Optimizing Care of Patients With Operable Hormone Receptor-Sensitive Breast Cancer

Machine learning-based spatial characterization of tumor-immune microenvironment in the EORTC 10994/BIG 1-00 early breast cancer trial

Axillary Surgery for Patients With Residual Isolated Tumor Cells (ypN0i+) After Neoadjuvant Systemic Therapy for Early Breast Cancer

Clinical Validity of Repeated Circulating Tumor Cell Enumeration as an Early Treatment Monitoring Tool for Metastatic Breast Cancer in the PREDICT Global Pooled Analysis

Expanding the role of CDK4/6 inhibitors in early breast cancer: insights from the NATALEE trial

Residual disease post neoadjuvant chemo-immunotherapy in early triple-negative breast cancer: does it help tailor adjuvant treatment?

Circulating tumor DNA validity and potential uses in metastatic breast cancer

Circulating tumor DNA for predicting recurrence in patients with operable breast cancer: a systematic review and meta-analysis

Reply to S. Di Cosimo et al

Reply to S. Di Cosimo et al

ctDNA as a predictive biomarker in advanced breast cancer: Lessons from the MONALEESA studies

Serum thymidine kinase activity in patients with hormone receptor-positive and HER2-negative metastatic breast cancer treated with palbociclib and fulvestrant

Liquid biopsy enters the clinic — implementation issues and future challenges

Association between the histopathological growth patterns of liver metastases and survival after hepatic surgery in breast cancer patients

Collaborators (10)

Laurence Buisseret

Catherine Alix-Panabières

Georgios C. Manikis

Ioannis Zerdes

Balazs Acs

Elisa Agostinetto

Stefanie Jeffrey

Ceren Boyaci

seamus o'reilly

Massimo Cristofanilli

Make your next move.